explore -WSS

explore

author：knowledge 2025-09-03 08:28:23 - browse：6849

AbbVie announced Tuesday that CEO Richard Gonzalez, who has managed the company’s ascent since it was spun off from the device maker Abbott Laboratories in 2013, will step down in July. Gonzalez had previously said he would depart when AbbVie had a plan in place to move on from its best-selling drug, Humira, which is now facing competition from cheaper biosimilars.

He will be replaced by Chief Operating Officer Robert Michael, who, like Gonzalez, is a longtime AbbVie executive. Gonzalez, 70, will become executive chairman of the board of directors.

Gonzalez should be a sobering reminder to the drug industry’s critics of how resilient a CEO’s reputation can be. Because while he has been a subject of nearly constant criticism for AbbVie’s handling of Humira and the patents protecting it, investors are likely to remember him fondly.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： After John Oliver segment, STAT readers share their opioid

explore

WSS

Trump, Nauta plead not guilty to new classified docs charges but De Oliveira still not arraigned

Target recalls 2.2 million additional candles due to laceration, burn hazards

GOP presidential candidates start declaring their loyalty

Newly revealed memo details efforts to keep Trump in power following election loss

The battle over 'scope creep' and who gets to be called 'doctor'

Pharma budget tightening trickles down to Doximity

hotspot

explore

hotspot

Cancer drug shortages should be causing more outrage

Iran moves toward freeing 5 American citizens who had been imprisoned, in rare deal

Medicare proposal to cover medical devices draws a mixed reaction

UHS says company favors patients whose insurance pays more

Wildfire smoke exposes gaps in outdoor worker protections

New Alzheimer's drugs heat up race for early detection blood tests

Alkermes shareholders re

Novo acquires Inversago for up to $1 billion

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What to watch for from Zogenix and Amicus clinical trials

Wikipedia

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

CDC Director Mandy Cohen on transparency, trust, and health

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

The battle over 'scope creep' and who gets to be called 'doctor'

Kim Kardashian sparks debate on benefits of full

New Alzheimer's drugs heat up race for early detection blood tests

hotspot

explore

leisure time

focus